AKT1 and hepatocellular carcinoma: Subsequent KEGG pathway analysis demonstrated widespread participation of DE‐miRNAs in metabolic and oncogenic pathways (e.g., Ras/PI3K‐Akt [39]), directly linking WD‐associated metabolic abnormalities to hepatocellular carcinoma risk.